Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis

Miklos Z. Molnar, Kiran Joglekar, Yu Jiang, George Cholankeril, Mubeen Khan Mohammed Abdul, Satish Kedia, Humberto C. Gonzalez, Aijaz Ahmed, Ashwani Singal, Kalyan Ram Bhamidimarri, Guruprasad Padur Aithal, Ajay Duseja, Vincent Wai‐Sun Wong, Agayeva Gulnare, Puneet Puri, Satheesh Nair, James D. Eason, Sanjaya K. Satapathy, the Global NAFLD Consortium – 28 October 2018 – Nonalcoholic steatohepatitis (NASH) is one of the top 3 indications for liver transplantation (LT) in Western countries.

Hepatology Highlights

Norihiro Imai, Tibor I. Krisko, Zaid H. Tafesh, Catherine Lucero, Michele Alves‐Bezerra, Hayley T. Nicholls, Sandra Steensels, Baran A. Ersoy, Russell Rosenblatt, Robert E. Schwartz, Vikas Gupta, Zurabi Lominadze, Brett E. Fortune – 27 October 2018

Hepatology Highlights

Norihiro Imai, Tibor I. Krisko, Zaid H. Tafesh, Catherine Lucero, Michele Alves‐Bezerra, Hayley T. Nicholls, Sandra Steensels, Baran A. Ersoy, Russell Rosenblatt, Robert E. Schwartz, Vikas Gupta, Zurabi Lominadze, Brett E. Fortune – 27 October 2018

PAPD5/7 Are Host Factors That Are Required for Hepatitis B Virus RNA Stabilization

Henrik Mueller, Anaïs Lopez, Philipp Tropberger, Steffen Wildum, Josephine Schmaler, Lykke Pedersen, Xingchun Han, Yongguang Wang, Søren Ottosen, Song Yang, John A.T. Young, Hassan Javanbakht – 26 October 2018 – RG7834 is a potent, orally bioavailable small‐molecule inhibitor of hepatitis B virus (HBV) gene expression that belongs to the dihydroquinolizinone (DHQ) chemical class and uniquely blocks production of both viral DNA and antigens.

Subscribe to